Add-on Effects of Valsartan on Morbi- Mortality (KYOTO HEART Study)
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
The KYOTO HEART Study is to assess the add-on effect of valsartan, an Angiotensin-Receptor
Blocker, on top of the conventional treatment in high risk patients in Japan with
hypertension in terms of the morbidity and mortality.